Logo

American Heart Association

  163
  0


Final ID:

Discussant: RSQ-777-02

  • Testani, Jeffrey  ( YALE , Guilford , Connecticut , United States )
  • Ommen, Steve  ( MAYO CLINIC , Rochester , Minnesota , United States )
  • Patel, Ravi  ( Northwestern University , Chicago , Illinois , United States )
  • Author Disclosures:
    Jeffrey Testani: DO NOT have relevant financial relationships | Steve Ommen: DO have relevant financial relationships ; Advisor:Cytokinetics:Past (completed) | Ravi Patel: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Building on the 4 Pillars: Novel Trials of Medical Therapy for Heart Failure

Monday, 11/18/2024 , 08:00AM - 09:15AM

Late-Breaking Science

More abstracts on this topic:
Sodium Zirconium Cyclosilicate and MRA Optimization in Heart Failure With Reduced Ejection Fraction and Hyperkalemia: Main Results From REALIZE-K Randomized Controlled Trial

Kosiborod Mikhail, Cherney David, Desai Akshay, Testani Jeffrey, Verma Subodh, Dahl Magnus, Eudicone James, Friberg Lovisa, Petrie Mark

Discussant: The SARAH Trial

Lopez-fernandez Teresa, Ky Bonnie

More abstracts from these authors:
The ICAM1 p.K56M HFpEF Risk Variant and Measures of Adiposity

Aneja Anushree, Culler Kasen, Ding Jingzhong, Raffield Laura, Ekunwe Lynette, Taylor Kent, Shah Sanjiv, Rasmussen-torvik Laura, Patel Ravi

Implementing Heart Failure GDMT in Advanced CKD: Key Considerations

Covic Adrian, Bali Atul, Testani Jeffrey, Tuttle Katherine, Bansal Nisha

You have to be authorized to contact abstract author. Please, Login
Not Available